Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06217783 · ClinicalTrials.gov registry record · NA
Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
A NA study of Oncologic Complications and Emergencies, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06217783: Recruiting NA study of Oncologic Complications and Emergencies, sponsored by M.D. Anderson Cancer Center.
NCT06217783 is a NA study of Oncologic Complications and Emergencies that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06217783, a NA study of Oncologic Complications and Emergencies, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Conditions Studied
Interventions
- DEVICE Introcan Safety IV Catheter
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What NCT06217783 shows while recruiting
NCT06217783 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Oncologic Complications and Emergencies appearing as the primary indexed condition, and to 1 intervention - of which Introcan Safety IV Catheter is the first listed.
NCT06217783 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06217783 about?
NCT06217783 is a clinical study titled "Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths". To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
What is the current status of trial NCT06217783?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-03-27. Estimated completion is 2027-12-01.
What conditions does trial NCT06217783 study?
This clinical trial studies the following conditions: Oncologic Complications and Emergencies.
What interventions are being tested in trial NCT06217783?
The interventions under investigation include: Introcan Safety IV Catheter (DEVICE).
Who is sponsoring clinical trial NCT06217783?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06217783 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06217783's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI